Dihydropyrimidine dehydrogenase in normal and malignant endometrium: Relationship with cell proliferation and thymidine phosphorylase

Virchows Archiv

Volumn 443, Issue 5, 2003, Pages 672-677

  Fujiwaki, Ritsuto ^a   Iida, Kohji ^a   Nakayama, Kentaro ^a   Kanasaki, Haruhiko ^a   Ozaki, Tomoya ^a   Hata, Kohkichi ^a   Sakai, Eiichi ^b   Miyazaki, Kohji ^a  

^a SHIMANE UNIVERSITY   (Japan)

^b Nihon Gene Res Laboratories Inc   (Japan)

Author keywords

Dihydropyrimidine dehydrogenase; Endometrial cancer; Endometrium; Proliferating cell nuclear antigen; Thymidine phosphorylase

Indexed keywords

CYCLINE; DIHYDROPYRIMIDINE DEHYDROGENASE; THYMIDINE; THYMIDINE PHOSPHORYLASE; THYMINE;

ARTICLE; CELL FUNCTION; CELL PROLIFERATION; CONTROLLED STUDY; ENDOMETRIUM CANCER; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MENSTRUAL CYCLE; NUCLEOTIDE SEQUENCE; POSTMENOPAUSE; PRIORITY JOURNAL; PROTEIN LOCALIZATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

CELL DIVISION; DIHYDROURACIL DEHYDROGENASE (NADP); ENDOMETRIAL NEOPLASMS; ENDOMETRIUM; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE EXPRESSION; HUMANS; IMMUNOHISTOCHEMISTRY; MENSTRUAL CYCLE; POSTMENOPAUSE; PROLIFERATING CELL NUCLEAR ANTIGEN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; THYMIDINE PHOSPHORYLASE;

EID: 0345491357     PISSN: 09456317     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00428-003-0866-3     Document Type: Article

References (28)

1. Brown NS, Bicknell R (1998) Thymidine phosphorylase, 2-deoxy-D-ribose and angiogenesis. Biochem J 334:1-8
2. Canellakis ES (1956) Pyrimidine metabolism-enzymatic pathways of uracil and thymidine degradation. J Biol Chem 221:315-322
3. Eda H, Fujimoto K, Watanabe S, Ura M, Hino A, Tanaka Y, Wada K, Ishitsuka H (1993) Cytokines induce thymidine phosphorylase expression in tumor cells and make them more susceptible to 5′-deoxy-5-fluorouridine. Cancer Chemother Pharmacol 32:333-338
4. Fink RM, Fink K, Henderson RB (1955) Beta-amino acid formation by tissue slices incubated with pyrimidines. J Biol Chem 201:349-355
5. Fujimoto J, Ichigo S, Sakaguchi H, Hirose R, Tamaya T (1998) Expression of platelet-derived endothelial cell growth factor and its mRNA in uterine endometrium during the menstrual cycle. Mol Hum Reprod 4:509-513
6. Fujiwaki R, Hata K, Iida K, Koike M, Miyazaki K (1998) Immunohistochemical expression of thymidine phosphorylase in human endometrial cancer. Gynecol Oncol 68:247-252
7. Fujiwaki R, Hata K, Iida K, Maede Y, Koike M, Miyazaki K (1999) Thymidine phosphorylase expression in progression of cervical cancer: correlation with microvessel count, proliferating cell nuclear antigen, and apoptosis. J Clin Pathol 52:598-603
8. Fujiwaki R, Hata K, Nakayama K, Fukumoto M, Miyazaki K (2000) Gene expression for dihydropyrimidine dehydrogenase and thymidine phosphorylase influences outcome in epithelial ovarian cancer. J Clin Oncol 18:3946-3951
9. Fujiwaki R, Hata K, Nakayama K, Moriyama M, Iwanari O, Katabuchi H, Okamura H, Sakai E, Miyazaki K (2002) Thymidine kinase in epithelial ovarian cancer: relationship with the other pyrimidine pathway enzymes. Int J Cancer 99:328-335
10. Griffiths L, Dachs GU, Bicknell R, Harris AL, Stratford IJ (1997) The influence of oxygen tension and pH on the expression of platelet-derived endothelial cell growth factor/ thymidine phosphorylase in human breast tumor cells grown in vitro and in vivo. Cancer Res 57:570-572
11. Ho DH, Townsend L, Luna MA, Bodey GP (1986) Distribution and inhibition of dihydrouracil dehydrogenase activities in human tissues using 5-fluorouracil as a substrate. Anticancer Res 6:781-784
12. Iltzsch MH, el Kouni MH, Cha S (1985) Kinetic studies of thymidine phosphorylase from mouse liver. Biochemistry 24:6799-6807
13. Ishikawa F, Miyazono K, Hellman U, Drexler H, Wernstedt C, Hagiwara K, Usuki K, Takaku F, Risau W, Heldin CH (1989) Identification of angiogenic activity and the cloning and expression of platelet-derived endothelial cell growth factor. Nature 338:557-562
14. Ishikawa T, Sekiguchi F, Fukase Y, Sawada N, Ishitsuka H (1998) Positive correlation between the efficacy of capecitabine and doxifluridine and the ratio of thymidine phosphorylase to dihydropyrimidine dehydrogenase activities in tumors in human cancer xenografts. Cancer Res 58:685-690
15. Jiang W, Lu Z, He Y, Diasio RB (1997) Dihydropyrimidine dehydrogenase activity in hepatocellular carcinoma: implication in 5-fluorouracil-based chemotherapy. Clin Cancer Res 3:395-399
16. Kitazono M, Takebayashi Y, Ishitsuka K, Takao S, Tani A, Furukawa T, Miyadera K, Yamada Y, Aikou T, Akiyama S (1998) Prevention of hypoxia-induced apoptosis by the angiogenic factor thymidine phosphorylase. Biochem Biophys Res Commun 253:797-803
17. McLeod HL, Sludden J, Murray GI, Keenan RA, Davidson AI, Park K, Koruth M, Cassidy J (1998) Characterization of dihydropyrimidine dehydrogenase in human colorectal tumours. Br J Cancer 77:461-465
18. Moghaddam A, Zhang HT, Fan TP, Hu DE, Lees VC, Turley H, Fox SB, Gatter KC, Harris AL, Bicknell R (1995) Thymidine phosphorylase in angiogenic and promotes tumor growth. Proc Natl Acad U S A 92:998-1002
19. Mori K, Hasegawa M, Nishida M, Toma H, Fukuda M, Kubota T, Nagasue N, Yamana H, Hirakawa-YS Chung K, Ikeda T, Takasaki K, Oka M, Kameyama M, Toi M, Fujii H, Kitamura M, Murai M, Sasaki H, Ozono S, Makuuchi H, Shimada Y, Onishi Y, Aoyagi S, Mizutani K, Ogawa M, Nakao A, Kinoshita H, Tono T, Imamoto H, Nakashima Y, Manabe T (2000) Expression levels of thymidine phosphorylase and dihydropyrimidine dehydrogenase in various human tumor tissues. Int J Oncol 17:33-38
20. Noyes RW, Hertig AT, Rock J (1955) Dating the endometrial biopsy. Fertil Steril 1:3-25
21. Naguib FN, el Kouni MH, Cha S (1985) Enzymes of uracil catabolism in normal and neoplastic human tissues. Cancer Res 45:5405-5412
22. Okabe H, Arakawa K, Takechi S, Fukushima M (2000) Expression of recombinant human dihydropyrimidine dehydrogenase and its application to the preparation of anti-DPD antibodies for immunohistochemical detection. Jpn J Cancer Chemother 27:891-898
23. Osuga Y, Toyoshima H, Mitsuhashi N, Taketani Y (1995) The presence of platelet-derived endothelial cell growth factor in human endometrium and its characteristic expression during the menstrual cycle and early gestational period. Hum Reprod 10:989-993
24. Queener SF, Morris HP, Weber G (1971) Dihydrouracil dehydrogenase activity in normal, differentiating, and regenerating liver and hepatomas. Cancer Res 31:1004-1009
25. Terashima M, Fujiwara H, Takagane A, Abe K, Araya M, Irinoda T, Yonezawa H, Nakaya T, Oyama K, Takahashi M, Saito K (2002) Role of thymidine phosphorylase and dihydropyrimidine dehydrogenase in tumour progression and sensitivity to doxifluridine in gastric cancer patients. Eur J Cancer 38:2375-2381
26. Tuchman M, Ramnaraine ML, O'Dea RF (1985) Effects of uridine and thymidine on the degradation of 5-fluorouracil, uracil, and thymine by rat liver dihydropyrimidine dehydrogenase. Cancer Res 45:5553-5556
27. Tuchman M, O'Dea RF, Ramnaraine ML, Mirkin BL (1988) Pyrimidine base degradation in cultured murine C-1300 neuroblastoma cells and in situ tumors. J Clin Invest 81:425-430
28. Zhang L, Mackenzie IZ, Rees MC, Bicknell R (1997) Regulation of the expression of the angiogenic enzyme platelet-derived endothelial cell growth factor/thymidine phosphorylase in endometrial isolates by ovarian steroids and cytokines. Endocrinology 138:4921-4930